ATE507243T1 - Verfahren zur senkung des blutdrucks - Google Patents

Verfahren zur senkung des blutdrucks

Info

Publication number
ATE507243T1
ATE507243T1 AT06759197T AT06759197T ATE507243T1 AT E507243 T1 ATE507243 T1 AT E507243T1 AT 06759197 T AT06759197 T AT 06759197T AT 06759197 T AT06759197 T AT 06759197T AT E507243 T1 ATE507243 T1 AT E507243T1
Authority
AT
Austria
Prior art keywords
blood pressure
reducing
lowering blood
agents
methods
Prior art date
Application number
AT06759197T
Other languages
English (en)
Inventor
Parobok Ingrid Langsetmo
Todd Seeley
Robert Stephenson
Original Assignee
Fibrogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc filed Critical Fibrogen Inc
Application granted granted Critical
Publication of ATE507243T1 publication Critical patent/ATE507243T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Fuel Cell (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06759197T 2005-09-29 2006-05-05 Verfahren zur senkung des blutdrucks ATE507243T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72230205P 2005-09-29 2005-09-29
PCT/US2006/017507 WO2007040636A1 (en) 2005-09-29 2006-05-05 Methods for reducing blood pressure

Publications (1)

Publication Number Publication Date
ATE507243T1 true ATE507243T1 (de) 2011-05-15

Family

ID=36971225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06759197T ATE507243T1 (de) 2005-09-29 2006-05-05 Verfahren zur senkung des blutdrucks

Country Status (10)

Country Link
US (1) US20070072817A1 (de)
EP (1) EP1942985B1 (de)
JP (1) JP2009510056A (de)
CN (1) CN101316626A (de)
AT (1) ATE507243T1 (de)
AU (1) AU2006297839B2 (de)
CA (1) CA2623693A1 (de)
DE (1) DE602006021600D1 (de)
IL (1) IL190496A0 (de)
WO (1) WO2007040636A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946172B2 (en) 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
NZ601660A (en) 2008-08-25 2014-05-30 Excaliard Pharmaceuticals Inc Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
PT2670411T (pt) 2011-02-02 2019-06-18 Excaliard Pharmaceuticals Inc Compostos anti sentido visando um fator de crescimento do tecido conetivo (ctfg) para utilização num método de tratamento de queloides ou cicatrizes hipertróficas
PL2986308T3 (pl) 2013-12-18 2020-05-18 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotensyna ii w połączeniu do leczenia niedociśnienia
WO2016007589A1 (en) * 2014-07-08 2016-01-14 La Jolla Pharmaceutical Company Methods for treating hypotension
PL3400000T3 (pl) 2016-01-07 2024-04-22 La Jolla Pharma, Llc Sposoby podawania angiotensyny ii
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227851A (ja) * 1983-06-09 1984-12-21 Sankyo Co Ltd レニン阻害作用を有するペプチド類
US4699905A (en) * 1984-04-10 1987-10-13 Sankyo Company, Limited Perhydrothiazepine derivatives, their preparation and their therapeutic use
US5194605A (en) * 1989-12-08 1993-03-16 Merck & Co., Inc. Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
US5708029A (en) * 1995-11-13 1998-01-13 Vanmoor; Arthur High blood pressure relief method and compositions
AU5613999A (en) * 1998-09-18 2000-04-10 University Of British Columbia, The Pharmaceutical compositions of vanadium biguanide complexes and their use
WO2001066140A1 (en) * 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
US7405274B2 (en) * 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
US20100004304A1 (en) * 2004-03-16 2010-01-07 Kohn Leonard D Methods and compositions for the treatment of malignant melanoma, breast, prostate, colon, papillary thyroid and pancreatic cancer
CA2599550A1 (en) * 2005-03-11 2006-09-21 Elixir Pharmaceuticals, Inc. Sirt inhibitors that bind to nad
US8048880B2 (en) * 2007-05-03 2011-11-01 Anthera Pharmaceuticals, Inc. Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism

Also Published As

Publication number Publication date
DE602006021600D1 (de) 2011-06-09
AU2006297839B2 (en) 2011-04-14
IL190496A0 (en) 2008-11-03
WO2007040636A1 (en) 2007-04-12
AU2006297839A1 (en) 2007-04-12
EP1942985B1 (de) 2011-04-27
EP1942985A1 (de) 2008-07-16
JP2009510056A (ja) 2009-03-12
HK1121083A1 (en) 2009-04-17
CN101316626A (zh) 2008-12-03
CA2623693A1 (en) 2007-04-12
US20070072817A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
EP2068768A4 (de) Verfahren und system zur verbesserung der diastolischen herzfunktion
DE602005017840D1 (de) Blutdruckmonitor
DE602006002756D1 (de) Manschette für Blutdruckmessgerät, Herstellungsverfahren hierfür und Blutdruckmessgerät
EA200802213A1 (ru) Способы лечения заболеваний крови
ATE532518T1 (de) Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
DK2324871T4 (da) Citratantikoaguleringssystem til ekstrakorporale blodbehandlinger
ITMO20040191A1 (it) Macchina e metodo per il trattamento extracorporeo di sangue.
DK3357911T3 (da) Prolylhydroxylaseinhibitorer og fremgangsmåder til anvendelse
ATE470354T1 (de) Systeme und verfahren für die ex-vivo-organpflege
DE602006011828D1 (de) Methoden zur Herstellung von Katheterschaftröhren
DE602005024846D1 (de) Blutdialysator
WO2007056681A3 (en) Methods for administering hypoglycemic agents
DE602005026030D1 (de) Blutdruckmessgerät
IL190496A0 (en) Methods for reducing blood pressure
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
NO20076241L (no) Terapier for vaskulaere sykdommer
SMT201300116B (it) Procedimenti e intermedi per la preparazione di uninibitore macrociclico di proteasi di hcv
WO2006055981A3 (en) Use of cutured three-dimensional tissue for treating congestive heart failure
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602005012481D1 (de) 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck
ZA200708576B (en) Blood pressure lowering protein hydrolysates
WO2007038264A3 (en) Gapr-1 methods
DE602005004393D1 (de) Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet
ATE530660T1 (de) Enzymatische herstellung von (meth)acrylsäureestern
MX2008009161A (es) Tratamiento de enfermedad cardiovascular en mexicano-americanos, usando nebivolol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties